SCHEMBL23536162

SCHEMBL23536162

O=Cc1ccccc1N1CCC(c2c(F)cccc2F)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.45
NOTUM Q6P988 1/20 0.43
ABCB1 P08183 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
TSHR P16473 2/20 0.40
ERN1 O75460 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.39
USP2 O75604 1/20 0.39
NTSR1 P30989 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23536314 0.79 GRM2 (0.43) GRM2ERN1
SCHEMBL28614790 0.78 DHFR (0.48) GRM2
SCHEMBL24105734 0.77 ERN1 (0.50) ABCB1ERN1KMT2AMEN1
SCHEMBL30340411 0.77 ERN1 (0.50) ABCB1ERN1KMT2AMEN1
SCHEMBL24105749 0.76 ERN1 (0.48) ABCB1ERN1KMT2AMEN1
SCHEMBL29931899 0.75 GRM2 (0.44) GRM2NOTUMABCB1CYP1A2CYP2C9
SCHEMBL23536325 0.75 GRM2 (0.44) GRM2NOTUMABCB1CYP1A2CYP2C9
SCHEMBL23535976 0.75 GRM2 (0.44) GRM2NOTUMABCB1CYP1A2CYP2C9
SCHEMBL6223691 0.74 KMT2A (0.41) NOTUMALDH1A1KMT2AMEN1GAA
SCHEMBL5160655 0.74 MEN1 (0.59) SMN1; SMN2ALDH1A1KDM4ETSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076423-A1 TRPML MODULATORS Casma Therapeutics, Inc. (US) 2022-10-26 EP disclosed
CN-115087440-A TRPML modulators 卡斯玛治疗公司 2022-09-20 CN disclosed
WO-2021127337-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed